Language
English
Publication Date
6-1-2025
Journal
Pharmacology & Therapeutics
DOI
10.1016/j.pharmthera.2025.108849
PMID
40204142
PMCID
PMC13108698
PubMedCentral® Posted Date
4-25-2026
PubMedCentral® Full Text Version
Author MSS
Abstract
G-protein coupled receptors (GPCR) are one of the frequently investigated drug targets. GPCRs are involved in many human pathophysiologies that lead to various disease conditions, such as cancer, diabetes, and obesity. GPCR receptor activates multiple signaling pathways depending on the ligand and tissue type. However, this review will be limited to the GPCR-mediated metabolic modulations and the activation of relevant signaling pathways in cancer therapy. Cancer cells often have reprogrammed cell metabolism to support tumor growth and metastatic plasticity. Many aggressive cancer cells maintain a hybrid metabolic status, using both glycolysis and mitochondrial metabolism for better metabolic plasticity. In addition to glucose and glutamine pathways, fatty acid is a key mitochondrial energy source in some cancer subtypes. Recently, targeting alternative energy pathways like fatty acid beta-oxidation (FAO) has attracted great interest in cancer therapy. Several in vitro and in vivo experiments in different cancer models reported encouraging responses to FAO inhibitors. However, due to the potential liver toxicity of FAO inhibitors in clinical trials, new approaches to indirectly target metabolic reprogramming are necessary for in vivo targeting of cancer cells. This review specifically focused on free fatty acid receptors (FFAR) and β-adrenergic receptors (β-AR) because of their reported significance in mitochondrial metabolism and cancer. Further understanding the pharmacology of GPCRs and their role in cancer metabolism will help repurpose GPCR-targeting drugs for cancer therapy and develop novel drug discovery strategies to combine them with standard cancer therapy to increase anticancer potential and overcome drug resistance.
Keywords
Humans, Neoplasms, Receptors, G-Protein-Coupled, Animals, Signal Transduction, Fatty Acids, Mitochondria, Antineoplastic Agents, Energy Metabolism, Metabolic Reprogramming, mitochondria metabolism, cancer, free fatty acid receptors, β-adrenergic receptors
Published Open-Access
yes
Recommended Citation
Songyeon Ahn and Benny Abraham Kaipparettu, "G-Protein Coupled Receptors in Metabolic Reprogramming and Cancer" (2025). Faculty, Staff and Students Publications. 7139.
https://digitalcommons.library.tmc.edu/baylor_docs/7139